ZIVO BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was -54.39K shares.
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was 65.27K shares.
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-03-31 was 1.36M shares, a 0.00% change year-over-year.
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-09-30 was -2.12M shares, a 101.48% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2023-09-30 | -54.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | |
| 2023-06-30 | 65.27K shares 10-Q · filed 2024-08-14 | |
| 2021-03-31 | 1.36M shares 10-Q · filed 2021-05-17 | |
| 2020-09-30 | -2.12M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | |
| 2020-06-30 | 832.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | |
| 2020-03-31 | 1.36M shares 10-Q · filed 2020-11-12 | |
| 2019-09-30 | 143.45M shares 10-Q · filed 2020-11-12 | |
| 2019-06-30 | 143.45M shares 10-Q · filed 2020-08-13 | |
| 2019-03-31 | 4.65M shares 10-Q · filed 2020-11-12 |